The revised $123-per-share cash offer for Synaptics changes the trading conversation immediately. For $SYNA holders, the consideration is a direct valuation catalyst. For $ON shareholders, it is a larger test: Onsemi is presenting the transaction as a source of immediate earnings-per-share accretion and higher shareholder value, but the market will still assess execution.

This is no longer simply a semiconductor acquisition story. It is a live event for merger-arbitrage traders, options participants and shareholders measuring whether the revised economics justify the additional transaction exposure. The announced terms provide a clear headline number, but they do not eliminate the need to evaluate deal-close risk.

Under the revised merger agreement, Onsemi agreed to acquire Synaptics for $123 per share in cash. The companies’ announcement characterizes the revised terms as delivering higher value for Onsemi shareholders through immediate EPS accretion. That combination creates two distinct market questions: how much value does the higher offer deliver to $SYNA holders, and how confidently can $ON shareholders underwrite the execution required to realize the stated benefits?

A direct catalyst for Synaptics shareholders

For Synaptics shareholders, the revised consideration is straightforward. The transaction now carries a specified cash offer of $123 per share, giving the market a concrete reference point for evaluating the company’s standalone valuation against the proposed merger consideration.

That clarity can draw attention from merger-arbitrage traders. The relevant opportunity set typically centers on the difference between a target’s trading price and the announced cash consideration, but the assignment provides no current market price and therefore no spread to calculate. What can be said is that the higher offer may increase the importance of the spread, the perceived probability of completion and the timing of any eventual close in traders’ analysis.

The revised terms may also keep $SYNA options activity in focus. Participants could use options to express views on deal-close risk and the range of outcomes implied by the cash consideration. Elevated volume or volatility would be a possible consequence of that positioning, not a confirmed market outcome.

Onsemi faces a valuation and execution test

For Onsemi shareholders, the rationale is more demanding than a simple headline increase. Management is pointing to immediate EPS accretion and higher shareholder value, making the revised agreement a significant valuation event for $ON. The market may now scrutinize whether the stated accretion case can translate into durable value after the transaction is completed.

That scrutiny could influence $ON trading and options activity as participants weigh the strategic logic against execution risk. Options markets may reflect changing expectations around the acquisition, but the announced materials do not provide enough information to characterize a specific implied move, volatility level or valuation multiple. Discipline matters here: the transaction supplies a $123 cash consideration and an accretion claim, not a guaranteed outcome.

A broader semiconductor consolidation signal

The revised agreement also sends a broader signal about consolidation appetite in semiconductors heading into the fourth-quarter earnings season. Companies pursuing transactions that management frames as immediately accretive are effectively asking shareholders to judge both strategic fit and capital allocation at a sensitive point in the sector cycle.

That makes the Onsemi-Synaptics transaction relevant beyond the two tickers. It may serve as a reference point for traders tracking semiconductor M&A, particularly where acquisition premiums, cash consideration and earnings accretion shape the market’s response. Still, no additional deal terms, closing date or market prices were announced in the supplied materials.

The bottom line is clear but bounded: $SYNA receives a higher stated cash consideration of $123 per share, while $ON must demonstrate that immediate EPS accretion can support the higher shareholder-value case. As the market digests the revised agreement, merger-arbitrage activity, options volume and volatility may rise around both securities—but the size and direction of any move remain matters for the market to determine. The company announcement details the revised merger agreement and its stated EPS-accretion rationale.